Charles Elliott Sigal, Director at Vir Biotechnology, Inc. (VIR), bought 5,000 shares at $25.60 ($127K) on 2023-01-03, disclosed to the SEC on 2023-01-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.60 | 2,500 | $64K | 50.3% |
| 2 | $25.25 | 2,500 | $63K | 49.7% |
| Total | $25.43 avg | 5,000 | $127K | 100% |
| Filing → |
| ADAP | BUY | 2016-05-19 | $23K | — | Filing → |
| ADAP | BUY | 2016-05-18 | $69K | — | Filing → |